Inhaled gene therapy for multiple lung nodules
Part of Cancer, Lungs & breathing clinical trials.
This study tests an inhaled treatment that uses a special virus to deliver a healthy p53 gene (a gene that helps control cell growth) directly to lung nodules. It aims to see if this inhaled therapy can treat or prevent the progression of ground-glass lung nodules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to have at least one lung nodule (a small spot seen on a CT scan) that is between half a centimeter and 3 centimeters, and you may have several nodules.
- At least one of these nodules must have been checked by a biopsy (a small sample) and found to be cancer or pre-cancer.
- You should have a life expectancy of at least 12 weeks (about 3 months).
- Your lung function should be good enough, as measured by a breathing test (FEV1 at least 70% of what is expected).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat people who have several lung nodules (spots) by combining two procedures: robot-guided ablation (using heat or cold to destroy a nodule) and keyhole surgery (small cuts) to remove the main nodule. The goal is to treat all nodules while saving as much healthy lung as possible.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This trial is testing a new treatment using your own immune cells (called NK cells) to fight leftover high-risk lung nodules that cannot be surgically removed. It is for people who have already had some cancerous nodules removed and are looking for another option.
This trial tests a new inhaled mRNA therapy that may help your immune system fight cancer. It is for people with advanced lung cancer or cancer that has spread to the lungs when standard treatments have stopped working.
This trial tests a robot-assisted procedure that uses heat or cold to destroy lung spots (ground-glass nodules) without surgery. It may be an option if you cannot have surgery or prefer not to, and the spots are persistent and need treatment.
This trial tests an immunotherapy approach to stop high-risk lung spots from turning into cancer. It is for people who are current or former heavy smokers with multiple slow-growing lung nodules that are not yet ready for surgery.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.